Is Pulse Pressure a Predictor of New-Onset Diabetes in High-Risk Hypertensive Patients?
A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial
Article Information
vol. 33 no. 5 1122-1127
PubMed
Published By
Print ISSN
Online ISSN
History
- Received August 4, 2009
- Accepted February 8, 2010
- Published in print April 28, 2010.
- Published online ahead of print February 25, 2010.
Article Versions
- Previous version (February 25, 2010 - 11:14).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Shinji Yasuno, MD, PHD1,
- Kenji Ueshima, MD, PHD1,
- Koji Oba, MS1,
- Akira Fujimoto, MS1,
- Masakazu Hirata, MD, PHD2,
- Toshio Ogihara, MD, PHD3,
- Takao Saruta, MD, PHD4 and
- Kazuwa Nakao, MD, PHD1,2
- 1EBM Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan;
- 2Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan;
- 3Osaka General Medical Center, Osaka, Japan;
- 4Keio University School of Medicine, Tokyo, Japan.
- Corresponding author: Shinji Yasuno, syasuno{at}kuhp.kyoto-u.ac.jp.
Statistics from Altmetric.com
Article usage
In this Issue
May 2010, 33(5)
Is Pulse Pressure a Predictor of New-Onset Diabetes in High-Risk Hypertensive Patients?
